Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Access Criminology and Criminal Justice journals now

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Correctional Health Care
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Newman, S. B.
Right arrow Articles by Gaydos, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Newman, S. B.
Right arrow Articles by Gaydos, C. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Should Female Federal Inmates Be Screened for Chlamydial and Gonococcal Infection?

Sara B. Newman, MCP, DrPH

U.S. Public Health Service, Division of Immigration Health Services, Washington, DC; 10 N. Fillmore St., Arlington, VA 22201; sara.newman{at}dhs.gov

Michael B. Nelson, DO

Health Services Division of the Federal Bureau of Prisons, Washington, DC

Heidi B. Friedman, PhD

National Institute of Allergy and Infectious Diseases, Rockville, MD

Charlotte A. Gaydos, MS, DrPH

Chlamydia Laboratory, The Johns Hopkins University, Baltimore, MD

The study was implemented to assist the Federal Bureau of Prisons (BOP) in designing a rational chlamydial and gonococcal screening protocol for female inmates based on prevalence of infection. Surveys were administered and urine and swab specimens collected from study participants. At the prison where women were screened at entry, 1.2% tested positive for CT and 0.3% tested positive for GC. At the prison where women were not screened, 2.3% were positive for CT; no GC cases were identified. At this site, young age (18-22 years) was the most important factor associated with infection (RR 6.4), where a prevalence of 8.5% was found. Prevalence among women age 30 and younger exceeded 3.5%O. Screening women age 30 and younger would identify more than 60% of cases at an estimated cost of less than $60,000 per year at this site. It is recommended that women 30 years of age and younger be screened at intake for chlamydial infection at federal prisons.

Journal of Correctional Health Care, Vol. 11, No. 2, 137-155 (2005)
DOI: 10.1177/107834580401100203


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Correct Health CareHome page
J. C. Frye, L. Wallace, R. S. Chavez, and D. A. Luce
Screening and Treatment Guidelines for Chlamydia trachomatis in Incarcerated Adolescents: A Review
Journal of Correctional Health Care, April 1, 2008; 14(2): 89 - 98.
[Abstract] [PDF]